SCHEMBL20780339

SCHEMBL20780339

CCCCCc1cc(C(F)(F)F)ccc1NC(=O)OCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ2 O43526 3/20 0.48
KCNQ3 O43525 2/20 0.48
PLK1 P53350 1/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
KCNQ4 P56696 1/20 0.45
KCNQ5 Q9NR82 1/20 0.45
ALDH1A1 P00352 3/20 0.44
GAA P10253 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TRPV1 Q8NER1 1/20 0.43
POLB P06746 1/20 0.42
GPR35 Q9HC97 1/20 0.41
THRB P10828 1/20 0.41
PPARG P37231 2/20 0.40
PPARD Q03181 2/20 0.40
PPARA Q07869 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL463622 0.78 CYP1A2 (0.54) KCNQ2KCNQ3CYP1A2CYP2C9CYP2C19
SCHEMBL3888607 0.77 PLK1 (0.55) KCNQ2KCNQ3PLK1CYP1A2CYP2C9
SCHEMBL10939734 0.77 ALDH1A1 (0.54) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL10910110 0.77 ALDH1A1 (0.54) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL11292670 0.77 ALDH1A1 (0.54) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL18749963 0.76 SMN1; SMN2 (0.54) KCNQ2KCNQ3CYP1A2CYP2C9CYP2C19
SCHEMBL2539102 0.76 CYP1A2 (0.51) KCNQ2KCNQ3CYP1A2CYP2C9CYP2C19
SCHEMBL6286603 0.76 CYP1A2 (0.51) KCNQ2KCNQ3CYP1A2CYP2C9CYP2C19
SCHEMBL29646429 0.75 NLRP3 (0.52) KCNQ2KCNQ3CYP1A2CYP2C9CYP2C19
SCHEMBL439922 0.75 NLRP3 (0.52) KCNQ2KCNQ3CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019043018-A1 METHODS FOR TREATING OR PREVENTING CARDIOVASCULAR DISORDERS AND LOWERING RISK OF CARDIOVASCULAR EVENTS DALCOR PHARMA UK LTD., STOCKPORT ZUG BRANCH (CH) 2019-03-07 WO disclosed